vs
Astrana Health, Inc.（ASTH）与CENTRAL GARDEN & PET CO（CENT）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是CENTRAL GARDEN & PET CO的1.5倍（$950.5M vs $617.4M），CENTRAL GARDEN & PET CO净利率更高（1.1% vs 0.7%，领先0.4%），Astrana Health, Inc.同比增速更快（42.9% vs -6.0%），Astrana Health, Inc.自由现金流更多（$-6.0M vs $-81.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -17.2%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Central Garden & Pet Co是总部位于美国的宠物用品及园艺产品供应商，主营宠物食品、护理用具、草坪养护用品、园艺配件等品类，产品通过大型商超、独立宠物店、园艺中心等渠道销往北美市场，旗下拥有多个行业知名消费品牌。
ASTH vs CENT — 直观对比
营收规模更大
ASTH
是对方的1.5倍
$617.4M
营收增速更快
ASTH
高出48.8%
-6.0%
净利率更高
CENT
高出0.4%
0.7%
自由现金流更多
ASTH
多$75.1M
$-81.0M
两年增速更快
ASTH
近两年复合增速
-17.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $617.4M |
| 净利润 | $6.6M | $6.8M |
| 毛利率 | — | 30.9% |
| 营业利润率 | 1.9% | 2.7% |
| 净利率 | 0.7% | 1.1% |
| 营收同比 | 42.9% | -6.0% |
| 净利润同比 | 184.4% | -51.2% |
| 每股收益（稀释后） | $0.12 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHCENT
| Q4 25 | $950.5M | $617.4M | ||
| Q3 25 | $956.0M | $678.2M | ||
| Q2 25 | $654.8M | $960.9M | ||
| Q1 25 | $620.4M | $833.5M | ||
| Q4 24 | $665.2M | $656.4M | ||
| Q3 24 | $478.7M | $669.5M | ||
| Q2 24 | $486.3M | $996.3M | ||
| Q1 24 | $404.4M | $900.1M |
净利润ASTHCENT
| Q4 25 | $6.6M | $6.8M | ||
| Q3 25 | $373.0K | $-9.8M | ||
| Q2 25 | $9.4M | $95.0M | ||
| Q1 25 | $6.7M | $63.6M | ||
| Q4 24 | $-7.8M | $14.0M | ||
| Q3 24 | $16.1M | $-34.2M | ||
| Q2 24 | $19.2M | $79.7M | ||
| Q1 24 | $14.8M | $62.0M |
毛利率ASTHCENT
| Q4 25 | — | 30.9% | ||
| Q3 25 | — | 29.0% | ||
| Q2 25 | — | 34.6% | ||
| Q1 25 | — | 32.8% | ||
| Q4 24 | — | 29.8% | ||
| Q3 24 | — | 25.2% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | — | 31.0% |
营业利润率ASTHCENT
| Q4 25 | 1.9% | 2.7% | ||
| Q3 25 | 2.0% | -0.9% | ||
| Q2 25 | 3.1% | 14.1% | ||
| Q1 25 | 3.3% | 11.2% | ||
| Q4 24 | 0.1% | 4.3% | ||
| Q3 24 | 5.9% | -4.8% | ||
| Q2 24 | 6.2% | 11.6% | ||
| Q1 24 | 7.5% | 10.4% |
净利率ASTHCENT
| Q4 25 | 0.7% | 1.1% | ||
| Q3 25 | 0.0% | -1.4% | ||
| Q2 25 | 1.4% | 9.9% | ||
| Q1 25 | 1.1% | 7.6% | ||
| Q4 24 | -1.2% | 2.1% | ||
| Q3 24 | 3.4% | -5.1% | ||
| Q2 24 | 3.9% | 8.0% | ||
| Q1 24 | 3.7% | 6.9% |
每股收益（稀释后）ASTHCENT
| Q4 25 | $0.12 | $0.11 | ||
| Q3 25 | $0.01 | $-0.16 | ||
| Q2 25 | $0.19 | $1.52 | ||
| Q1 25 | $0.14 | $0.98 | ||
| Q4 24 | $-0.14 | $0.21 | ||
| Q3 24 | $0.33 | $-0.51 | ||
| Q2 24 | $0.40 | $1.19 | ||
| Q1 24 | $0.31 | $0.93 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $721.1M |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | $779.3M | $1.6B |
| 总资产 | $2.2B | $3.6B |
| 负债/权益比越低杠杆越低 | — | 0.76× |
8季度趋势，按日历期对齐
现金及短期投资ASTHCENT
| Q4 25 | $429.5M | $721.1M | ||
| Q3 25 | $463.4M | $882.5M | ||
| Q2 25 | $342.1M | $713.0M | ||
| Q1 25 | $260.9M | $516.7M | ||
| Q4 24 | $290.8M | $618.0M | ||
| Q3 24 | $350.3M | $753.5M | ||
| Q2 24 | $327.7M | $570.4M | ||
| Q1 24 | $337.3M | $301.3M |
总债务ASTHCENT
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.2B |
股东权益ASTHCENT
| Q4 25 | $779.3M | $1.6B | ||
| Q3 25 | $775.5M | $1.6B | ||
| Q2 25 | $765.5M | $1.6B | ||
| Q1 25 | $745.4M | $1.5B | ||
| Q4 24 | $712.7M | $1.5B | ||
| Q3 24 | $704.6M | $1.6B | ||
| Q2 24 | $678.9M | $1.6B | ||
| Q1 24 | $653.5M | $1.5B |
总资产ASTHCENT
| Q4 25 | $2.2B | $3.6B | ||
| Q3 25 | $2.2B | $3.6B | ||
| Q2 25 | $1.4B | $3.7B | ||
| Q1 25 | $1.3B | $3.6B | ||
| Q4 24 | $1.4B | $3.5B | ||
| Q3 24 | $1.3B | $3.6B | ||
| Q2 24 | $1.3B | $3.6B | ||
| Q1 24 | $1.2B | $3.5B |
负债/权益比ASTHCENT
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.75× | ||
| Q2 25 | — | 0.75× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | 0.76× | ||
| Q2 24 | — | 0.75× | ||
| Q1 24 | — | 0.79× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $-70.2M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $-81.0M |
| 自由现金流率自由现金流/营收 | -0.6% | -13.1% |
| 资本支出强度资本支出/营收 | 0.3% | 1.8% |
| 现金转化率经营现金流/净利润 | -0.44× | -10.26× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $285.0M |
8季度趋势，按日历期对齐
经营现金流ASTHCENT
| Q4 25 | $-2.9M | $-70.2M | ||
| Q3 25 | $10.0M | $182.7M | ||
| Q2 25 | $90.9M | $265.5M | ||
| Q1 25 | $16.6M | $-46.9M | ||
| Q4 24 | $-10.9M | $-68.8M | ||
| Q3 24 | $34.0M | $203.1M | ||
| Q2 24 | $23.2M | $286.1M | ||
| Q1 24 | $6.0M | $-24.5M |
自由现金流ASTHCENT
| Q4 25 | $-6.0M | $-81.0M | ||
| Q3 25 | $7.4M | $171.9M | ||
| Q2 25 | $89.5M | $251.7M | ||
| Q1 25 | $13.6M | $-57.5M | ||
| Q4 24 | $-13.5M | $-74.9M | ||
| Q3 24 | $31.7M | $193.0M | ||
| Q2 24 | $20.4M | $272.5M | ||
| Q1 24 | $5.6M | $-33.9M |
自由现金流率ASTHCENT
| Q4 25 | -0.6% | -13.1% | ||
| Q3 25 | 0.8% | 25.3% | ||
| Q2 25 | 13.7% | 26.2% | ||
| Q1 25 | 2.2% | -6.9% | ||
| Q4 24 | -2.0% | -11.4% | ||
| Q3 24 | 6.6% | 28.8% | ||
| Q2 24 | 4.2% | 27.3% | ||
| Q1 24 | 1.4% | -3.8% |
资本支出强度ASTHCENT
| Q4 25 | 0.3% | 1.8% | ||
| Q3 25 | 0.3% | 1.6% | ||
| Q2 25 | 0.2% | 1.4% | ||
| Q1 25 | 0.5% | 1.3% | ||
| Q4 24 | 0.4% | 0.9% | ||
| Q3 24 | 0.5% | 1.5% | ||
| Q2 24 | 0.6% | 1.4% | ||
| Q1 24 | 0.1% | 1.0% |
现金转化率ASTHCENT
| Q4 25 | -0.44× | -10.26× | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | 2.79× | ||
| Q1 25 | 2.48× | -0.74× | ||
| Q4 24 | — | -4.91× | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | 3.59× | ||
| Q1 24 | 0.40× | -0.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CENT
| Garden Products Segment | $201.6M | 33% |
| Dogand Cat Products | $157.0M | 25% |
| Other Pet Products | $117.8M | 19% |
| Manufactured Product Other | $102.5M | 17% |
| Wild Bird Products | $38.5M | 6% |
